Ashfield Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $6.88M | Hold |
79,887
| – | – | 0.58% | 49 |
|
|
2022
Q2 | $7.28M | Hold |
79,887
| – | – | 0.57% | 50 |
|
|
2022
Q1 | $6.55M | Buy |
79,887
+854
| +1% | +$67.3K | 0.42% | 57 |
|
|
2021
Q4 | $6.06M | Sell |
79,033
-600
| -0.8% | -$47.8K | 0.39% | 61 |
|
|
2021
Q3 | $5.98M | Sell |
79,633
-616
| -0.8% | -$46.8K | 0.43% | 61 |
|
|
2021
Q2 | $6.24M | Sell |
80,249
-6,764
| -8% | -$503K | 0.45% | 58 |
|
|
2021
Q1 | $6.4M | Sell |
87,013
-1,127
| -1% | -$83.1K | 0.51% | 51 |
|
|
2020
Q4 | $6.88M | Sell |
88,140
-759
| -0.9% | -$58K | 0.56% | 48 |
|
|
2020
Q3 | $7.04M | Sell |
88,899
-36
| -0% | -$2.82K | 0.64% | 49 |
|
|
2020
Q2 | $6.56M | Buy |
88,935
+4,142
| +5% | +$312K | 0.65% | 48 |
|
|
2020
Q1 | $6.22M | Buy |
84,793
+299
| +0.4% | +$23.5K | 0.76% | 42 |
|
|
2019
Q4 | $7.33M | Sell |
84,494
-3,284
| -4% | -$270K | 0.73% | 43 |
|
|
2019
Q3 | $7.05M | Buy |
87,778
+2,297
| +3% | +$184K | 0.76% | 41 |
|
|
2019
Q2 | $6.84M | Sell |
85,481
-286
| -0.3% | -$21.9K | 0.73% | 42 |
|
|
2019
Q1 | $6.81M | Buy |
85,767
+381
| +0.4% | +$28.5K | 0.75% | 41 |
|
|
2018
Q4 | $6.23M | Buy |
85,386
+192
| +0.2% | +$13.6K | 0.81% | 36 |
|
|
2018
Q3 | $5.77M | Sell |
85,194
-119
| -0.1% | -$7.58K | 0.65% | 41 |
|
|
2018
Q2 | $4.94M | Hold |
85,313
| – | – | 0.62% | 43 |
|
|
2018
Q1 | $4.43M | Sell |
85,313
-947
| -1% | -$51.1K | 0.58% | 52 |
|
|
2017
Q4 | $4.63M | Sell |
86,260
-3,574
| -4% | -$198K | 0.6% | 52 |
|
|
2017
Q3 | $5.49M | Buy |
89,834
+7
| +0% | +$424 | 0.74% | 44 |
|
|
2017
Q2 | $5.49M | Buy |
89,827
+1,060
| +1% | +$64.5K | 0.75% | 44 |
|
|
2017
Q1 | $5.38M | Buy |
88,767
+15
| +0% | +$910 | 0.75% | 45 |
|
|
2016
Q4 | $4.99M | Sell |
88,752
-475
| -0.5% | -$27.8K | 0.49% | 67 |
|
|
2016
Q3 | $5.31M | Buy |
89,227
+367
| +0.4% | +$21.5K | 0.44% | 70 |
|
|
2016
Q2 | $4.88M | Hold |
88,860
| – | – | 0.39% | 69 |
|
|
2016
Q1 | $4.49M | Buy |
88,860
+242
| +0.3% | +$11.9K | 0.32% | 79 |
|
|
2015
Q4 | $4.47M | Sell |
88,618
-1,947
| -2% | -$98.2K | 0.31% | 76 |
|
|
2015
Q3 | $4.27M | Buy |
90,565
+2,655
| +3% | +$141K | 0.27% | 74 |
|
|
2015
Q2 | $4.78M | Buy |
87,910
+408
| +0.5% | +$22.9K | 0.26% | 75 |
|
|
2015
Q1 | $4.8M | Sell |
87,502
-2,166
| -2% | -$123K | 0.26% | 73 |
|
|
2014
Q4 | $4.86M | Hold |
89,668
| – | – | 0.23% | 76 |
|
|
2014
Q3 | $5.07M | Sell |
89,668
-891
| -1% | -$50K | 0.25% | 77 |
|
|
2014
Q2 | $5M | Sell |
90,559
-6,540
| -7% | -$357K | 0.24% | 78 |
|
|
2014
Q1 | $5.26M | Sell |
97,099
-1,834
| -2% | -$95K | 0.25% | 74 |
|
|
2013
Q4 | $4.72M | Sell |
98,933
-734
| -0.7% | -$33.6K | 0.23% | 75 |
|
|
2013
Q3 | $4.53M | Hold |
99,667
| – | – | 0.23% | 75 |
|
|
2013
Q2 | $4.42M | Buy |
+99,667
| New | +$4.45M | 0.24% | 78 |
|
Other funds holding MRK
Ashfield Capital Partners's MRK Position: Q3 2022 in Review
Ashfield Capital Partners held its Merck (MRK) position steady in Q3 2022 at 79,887 shares worth $6.88M. The position accounts for 0.58% of the portfolio, ranked #49.
Ashfield Capital Partners first reported a position in MRK in Q2 2013 and has held it in 38 quarters since. The position peaked at $7.33M in Q4 2019. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.
- Ashfield Capital Partners held 79,887 shares of Merck worth $6.88M as of Q3 2022.
- Ashfield Capital Partners left its Merck share count unchanged in Q3 2022.
- Merck made up 0.58% of Ashfield Capital Partners's portfolio in Q3 2022, its #49 holding.
- Ashfield Capital Partners first reported a position in Merck in Q2 2013 and has held it in 38 quarters since.
- Ashfield Capital Partners's Merck position peaked at $7.33M in Q4 2019.
- 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.
Based on Ashfield Capital Partners's 13F filing for Q3 2022, filed 10 Nov 2022.